Last edition
News about "CSF1R inhibitor"
UK MHRA Approves Vimseltinib for Tenosynovial Giant Cell Tumours
UK MHRA approves Deciphera Pharma’s vimseltinib for adults with tenosynovial giant cell tumours affecting movement or where surgery is not an option.
CSF1R Inhibitor | 18/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members